Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma | Zendy

Diana M Sobieraj | Zendy; Erin R. Weeda | Zendy; Elaine Nguyen | Zendy; Craig I Coleman | Zendy; C Michael White | Zendy; Stephen C. Lazarus | Zendy; Kathryn Blake | Zendy; Jason E. Lang | Zendy; William L. Baker | Zendy

Open Access

Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma

Author(s) -

Diana M Sobieraj,

Erin R. Weeda,

Elaine Nguyen,

Craig I Coleman,

C Michael White,

Stephen C. Lazarus,

Kathryn Blake,

Jason E. Lang,

William L. Baker

Publication year - 2018

Publication title -

jama

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.688

H-Index - 680

eISSN - 1538-3598

pISSN - 0098-7484

DOI - 10.1001/jama.2018.2769

Subject(s) - medicine , inhaled corticosteroids , asthma , association (psychology) , intensive care medicine , anesthesia , psychotherapist , psychology

Combined use of inhaled corticosteroids and long-acting β-agonists (LABAs) as the controller and the quick relief therapy termed single maintenance and reliever therapy (SMART) is a potential therapeutic regimen for the management of persistent asthma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research